Upcoming Events
Log In
Pricing
Free Trial

New Focus of Enhancement – Malignant

HIDE
PrevNext

0:01

So our next case is a 61-year-old

0:03

woman for high-risk screening,

0:05

and she's a BRCA2 gene mutation carrier.

0:08

All right, so here's our BRCA2 gene mutation

0:11

carrier patient for high-risk screening.

0:14

On our left side, we have our STIR

0:16

image, and on the right, we have

0:17

a post-contrast subtracted image.

0:20

And just going through from

0:24

the top, of course, this patient had

0:28

comparison studies as well because

0:30

she's been having screening every year.

0:39

And what we noticed was this enhancing focus,

0:46

with kind of borderline focus

0:49

slash small mass because it was

0:51

close to 5 mm in size.

0:54

And when you look at the corresponding

0:55

image on the STIR, it's STIR hypointense,

0:59

there's nothing really there that we're seeing.

1:03

And it was new from previous, and if we go to one

1:09

on one layout and zoom in on this a little bit.

1:14

I think we can see that this is a little

1:18

bit more irregular in terms of its borders.

1:23

It's a little hard to see,

1:24

but it's not exactly a circumscribed

1:28

border as far as this focus goes.

1:30

So since this was new in a BRCA2 gene

1:34

mutation carrier, this was biopsied

1:36

and this turned out to be malignant.

1:38

So this was an invasive lobular carcinoma.

Report

Description

Faculty

Lisa Ann Mullen, MD

Assistant Professor; Breast Imaging Fellowship Director

Johns Hopkins Medicine

Tags

Women's Health

Neoplastic

MRI

Breast

© 2024 Medality. All Rights Reserved.

Contact UsTerms of UsePrivacy Policy